Melanoma is a fast-progressing skin cancer characterized by a high mortality rate after metastasis. Local chemotherapy could be considered a therapeutic approach only in stage 0 of progression (in situ melanoma) and in the postoperative phase after surgical removal of suspected skin lesions. For this purpose, drugs such as Imiquimod, 5-Fluorouracil, Dacarbazine, and Doxorubicin have been tested and shown positive effects. Recently, metal nanoparticles as separate therapeutic units or drug carriers have also fallen into the research focus.
2025
Green tea-derived nanosilver complex displays anti-melanoma activity
Melanoma is a fast-progressing skin cancer characterized by a high mortality rate after metastasis. Local chemotherapy could be considered a therapeutic approach only in stage 0 of progression (in situ melanoma) and in the postoperative phase after surgical removal of suspected skin lesions. For this purpose, drugs such as Imiquimod, 5-Fluorouracil, Dacarbazine, and Doxorubicin have been tested and shown positive effects. Recently, metal nanoparticles as separate therapeutic units or drug carriers have also fallen into the research focus.
Professor Scolyer’s huge announcement a year after declaring he is cancer-free
Professor Richard Scolyer AO, renowned scientist and 2024 joint Australian of the Year recipient, is leaving his role as co-medical director of the Melanoma Institute Australia.
Regional areas hit hardest in Victoria’s melanoma spike
A serious health concern has cast a shadow over the sunny days ahead for Victorians.